原发性干燥病外周血DNA甲基化改变先于淋巴瘤诊断
本研究纳入1998至2013年收集外周血DNA的原发性干燥病患者,比较6例日后发生淋巴瘤者与84例未发生淋巴瘤者的全表观基因组DNA甲基化,发现473个常染色体和1个X染色体差异甲基化CpG位点,富集于免疫激活、白细胞信号及囊泡介导分泌通路。结论提示独特DNA甲基化改变先于干燥病淋巴瘤发生,或有助于早期风险分层。
要点
- 干燥病患者淋巴瘤诊断前已存在外周血DNA甲基化差异。
- 差异甲基化位点主要呈低甲基化,涉及免疫调节与增殖相关基因。
- 该发现为整合表观遗传标志进行早期风险分层提供探索性框架。
核心结论
- 原发性干燥病患者在淋巴瘤诊断前已出现独特的外周血DNA甲基化改变,涉及免疫调节、细胞毒功能与增殖相关基因。
研究设计与样本
- 研究分析了1998至2013年收集的原发性干燥病患者外周血DNA,采用Illumina HumanMethylation450K BeadChip检测。
- 研究纳入6例采血后1年及以上发生淋巴瘤的干燥病患者(pre-lymphoma)与84例未发生淋巴瘤的干燥病患者(only SjD)。
- 全表观基因组关联分析校正年龄、性别和估计血细胞类型比例。
主要发现
- 共473个常染色体和1个X染色体差异甲基化CpG位点可区分pre-lymphoma患者与only SjD患者,其中87%的位点在pre-lymphoma患者中呈低甲基化。
- 最显著差异甲基化位点位于胸苷激酶1(TK1;P = 7.6 × 10-15,Δβ = -0.16),其后为FCER1G和MDH2。
- 功能注释显示差异甲基化位点富集于免疫激活、白细胞信号及囊泡介导分泌通路。
- pre-lymphoma患者自然杀伤细胞比例降低、单核细胞比例升高,提示免疫环境改变。
关键数值与推荐
- 差异甲基化CpG位点定义为Bonferroni校正P ≤ 1.3 × 10-7且|Δβ| > 0.05。
- 功能富集分析使用Enrichr与Interferome version 2.01。
临床怎么用
- 研究处于探索阶段,尚不能直接用于临床风险分层,需外部验证。
- 提示未来可整合表观遗传、临床和血清学标志物,用于干燥病患者淋巴瘤早期风险分层。
局限性
- 研究为探索性分析,pre-lymphoma组仅6例,结果需重复验证。
- 原文未报告外部验证队列或长期随访效能数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Primary Sjögren's disease (SjD) is a systemic autoimmune disease associated with an increased risk of lymphoma. The molecular mechanisms underlying lymphomagenesis remain poorly understood, and sensitive biomarkers for early identification of patients at high risk of developing lymphoma are lacking. This study investigated whether DNA methylation patterns in blood are associated with subsequent development of lymphoma in patients with SjD. METHODS: Peripheral blood DNA samples collected from patients with SjD between 1998 and 2013 were analyzed using the Illumina HumanMethylation450K BeadChip. There were 6 patients who developed lymphoma at one or more years after blood sampling, henceforth referred to as "patients with SjD pre-lymphoma"; 84 patients with SjD did not develop lymphoma, and they are henceforth referred to as "patients with only SjD." Epigenome-wide association analyses were adjusted for age, sex, and estimated blood cell-type proportions. Differentially methylated CpG positions (DMPs) were defined by Bonferroni-corrected P ≤ 1.3 × 10-7 and |Δβ| > 0.05. Functional enrichment was assessed using Enrichr and Interferome version 2.01. RESULTS: A total of 473 autosomal and 1 X-chromosomal DMPs distinguished patients with SjD pre-lymphoma from patients with only SjD, with 87% of DMPs being hypomethylated in patients with SjDpl. The most significant DMP mapped to Thymidine kinase 1 (TK1; P = 7.6 × 10-15, Δβ = -0.16), followed by FCER1G and MDH2. Functional annotation revealed enrichment for immune activation, leukocyte signaling, and vesicle-mediated secretion pathways. Patients with SjD pre-lymphoma also exhibited reduced natural killer cells and increased monocyte proportions, consistent with an altered immune milieu. CONCLUSION: Distinct DNA methylation changes precede lymphoma in SjD, affecting genes involved in immune regulation, cytotoxic function, and proliferation. Although exploratory and requiring replication, these findings provide a framework for integrating epigenetic, clinical, and serologic markers to inform early risk stratification in patients with SjD.
引用
- Lidberg H, Fugmann C, Imgenberg-Kreuz J, et al. Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease. Arthritis Rheumatol. 2026. PMID: 42421555. doi:10.1002/art.70271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。